Protein Engineering for Improved Pharmacologic Characteristics of Established Monoclonal Antibody-Based Therapeutics

Research output: Contribution to journalEditorial

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)863-864
Number of pages2
JournalClinical Pharmacokinetics
Volume53
Issue number10
DOIs
StatePublished - Jan 1 2014

Fingerprint

Protein Engineering
Monoclonal Antibodies
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Pharmacology
  • Medicine(all)

Cite this

Protein Engineering for Improved Pharmacologic Characteristics of Established Monoclonal Antibody-Based Therapeutics. / Meibohm, Bernd.

In: Clinical Pharmacokinetics, Vol. 53, No. 10, 01.01.2014, p. 863-864.

Research output: Contribution to journalEditorial

@article{2f3961c5b44843eabd6ce39be6cd6dbe,
title = "Protein Engineering for Improved Pharmacologic Characteristics of Established Monoclonal Antibody-Based Therapeutics",
author = "Bernd Meibohm",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s40262-014-0186-6",
language = "English (US)",
volume = "53",
pages = "863--864",
journal = "Clinical Pharmacokinetics",
issn = "0312-5963",
publisher = "Adis International Ltd",
number = "10",

}

TY - JOUR

T1 - Protein Engineering for Improved Pharmacologic Characteristics of Established Monoclonal Antibody-Based Therapeutics

AU - Meibohm, Bernd

PY - 2014/1/1

Y1 - 2014/1/1

UR - http://www.scopus.com/inward/record.url?scp=84918795323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918795323&partnerID=8YFLogxK

U2 - 10.1007/s40262-014-0186-6

DO - 10.1007/s40262-014-0186-6

M3 - Editorial

VL - 53

SP - 863

EP - 864

JO - Clinical Pharmacokinetics

JF - Clinical Pharmacokinetics

SN - 0312-5963

IS - 10

ER -